MS
Michael Sinclair
Director10% Owner

Michael Sinclair insider trades: Opiant Pharmaceuticals (OPNT) stock buys and sales

Director, Opiant Pharmaceuticals Last trade Jun 15, 2022 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2015
2
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 15, 2022OPNT↓ Sell$149K
Jun 9, 2022OPNT↓ Sell$97K
Jun 7, 2022OPNT↓ Sell$110K
Jun 3, 2022OPNT↓ Sell$275K
Aug 25, 2021OPNT↓ Sell$2.4M
Sep 12, 2019OPNT↓ Sell$751K
Jan 17, 2017OPNT↑ Buy$25K
Jan 15, 2015LLTP↓ Sell$6K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael Sinclair's insider trades

Michael Sinclair is a director at Opiant Pharmaceuticals (OPNT). Since Jan 15, 2015, Michael has reported 1 open-market purchase worth $25K and 7 sales worth $3.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (4 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPNT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.